61 ONCE DAILY PSI-7977 PLUS PEGIFN/RBV IN A PHASE 2B TRIAL: RAPID VIROLOGIC SUPPRESSION IN TREATMENT-NAIVE PATIENTS WITH HCV GT2/GT3
Jacob Lalezari,
E. Läwitz,
M. Rodríguez‐Torres,
Aasim Sheikh,
B. Freilich,
David R. Nelson,
Tarek Hassanein,
Malte Mäder,
E. Albanis,
William T. Symonds,
Journal of Hepatology · 2011 · 47 citations · 0 references